Reduced beta-adrenoceptor sensitivity in the elderly

Clinical Pharmacology and Therapeutics
R E VestalD G Shand

Abstract

The effect of age on sensitivity to both isoproterenol and propranolol has been investigated in 27 male volunteers aged 21 to 73 yr. The dose of isoproterenol (given as a rapid intravenous injection) required to increase the resting heart rate by 25 bpm (I25) increased with age. The I25 was repeated during an intravenous infusion of propranolol and the dose ratio (I25 after propranolol divided by the control I25) determined. This was related to the concentration of free propranolol in plasma. It was found that the effectiveness of any given free concentration diminished progressively with age. These data are consistent with a diminished responsiveness of the beta-adrenoceptor to both agonist and antagonist drugs with advancing years.

References

Jan 1, 1992·British Journal of Clinical Pharmacology·G A FordT F Blaschke
Nov 1, 1991·British Journal of Clinical Pharmacology·G J MacpheeH L Elliott
Mar 1, 1990·Aging : Clinical and Experimental Research·N MarchionniC Bürgisser
Jan 1, 1989·British Journal of Clinical Pharmacology·M S ElfellahJ L Reid
Apr 1, 1987·Drug Intelligence & Clinical Pharmacy·J O Covinsky
Jan 1, 1986·European Journal of Clinical Pharmacology·I GretzerF Sjöqvist
Nov 1, 1988·Journal of the American Geriatrics Society·P J Scarpace
Apr 1, 1988·Scandinavian Journal of Clinical and Laboratory Investigation·S R Johansson, A Hjalmarson
Feb 1, 1988·Journal of the American Geriatrics Society·L Nolan, K O'Malley
Dec 1, 1987·Experientia·W R JarischA L Goldberger
Nov 1, 1985·Pharmacotherapy·F PucinoI L Silbergleit
Jan 1, 1985·Journal of the American Geriatrics Society·I SaitoT Saruta
Jun 1, 1983·Journal of Clinical and Hospital Pharmacy·S Hutchison, L M Campbell
Jun 19, 1980·The New England Journal of Medicine·J Koch-WeserE O'Brien
Jan 1, 1983·Acta Medica Scandinavica. Supplementum·N J Christensen
May 6, 1982·The New England Journal of Medicine·D J GreenblattR I Shader
Oct 1, 1981·Australian and New Zealand Journal of Medicine·J W Paxton
Jan 1, 1983·Acta Medica Scandinavica·L Holmberg, L E Böttiger
Feb 1, 1983·British Journal of Clinical Pharmacology·J M Arnold, D G McDevitt
Jan 1, 1995·Anesthesia and Analgesia·A S BarakaA M Nader
Feb 1, 1995·Journal of the American Geriatrics Society·J L Fleg
Jan 1, 1996·The British Journal of Ophthalmology·P Diggory, W Franks
Oct 8, 1997·Cancer·R E Vestal
Feb 28, 1998·Postgraduate Medicine·E M Gilbert
Nov 4, 2000·The Journal of Asthma : Official Journal of the Association for the Care of Asthma·V BelliaG Cuttitta
Jun 18, 2002·The Journal of Biological Chemistry·Jason D KiltsMadan M Kwatra
Apr 3, 2003·The Journal of Clinical Hypertension·Ihab M HajjarTheodore A Kotchen
Jun 17, 2003·The Journal of Asthma : Official Journal of the Association for the Care of Asthma·Ozkan KizkinHakan Gunen
Dec 18, 2003·British Journal of Clinical Pharmacology·A A Mangoni, S H D Jackson
May 21, 2005·Drugs & Aging·Louis MerleJean-Pierre Charmes
Feb 15, 2011·Cardiology Research and Practice·Aurelio Leone
Apr 20, 2014·Physiological Reports·Matthew J HeffernanMatthew D Muller
May 21, 2015·Purinergic Signalling·Geoffrey Burnstock, Nicholas Dale
Aug 11, 2015·Medicine and Science in Sports and Exercise·Cemal OzemekLeonard A Kaminsky
Mar 1, 1988·British Journal of Clinical Pharmacology·M ScottT J Fitzsimons
Jul 1, 1981·British Journal of Clinical Pharmacology·J FeelyI H Stevenson

Related Concepts

Human Volunteers
Adrenergic beta-Agonists
Novodrin
Beta-adrenergic receptor
Plasma
Norepinephrine Receptors
Propranolol
Isoproterenol
Agonists
Age Factors

Related Feeds

Adrenergic Receptors: Trafficking

Adrenergic receptor trafficking is an active physiological process where adrenergic receptors are relocated from one region of the cell to another or from one type of cell to another. Discover the latest research on adrenergic receptor trafficking here.